Stockchecker on feminine hygiene products
FDA Roundup: Generic Naloxone, Pediatric Low-Grade Glioma Treatment
Check out important updates from the FDA for the week of April 22.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA Approves Generic OTC Naloxone Nasal Spray
Amneal Pharmaceuticals said its generic naloxone hydrochloride nasal spray is now available in the US following FDA approval.
FDA Grants Tovorafenib Approval to Treat Relapsed or Refractory Pediatric Low-Grade Glioma
The approval for tovorafenib (Ojemda) was based on data from the phase 2 FIREFLY-1 trial, in which the therapy demonstrated an overall repose rate of 67%.
FDA Issues CRL for Epidermolysis Bullosa Gene Therapy
Abeona Therapeutics’ pz-cel is an investigational autologous, COL7A1 gene-corrected epidermal sheet therapy for the treatment of recessive dystrophic epidermolysis bullosa.
FDA Roundup: Biosimilars, Boxed Warning Added for CAR T-Cell Therapies
Check out important updates from the FDA for the week of April 15.
